The Current Ratio as of June 2026 (TTM) for Prescient Therapeutics Limited (PSTTF) is 12.95

According to Prescient Therapeutics Limited’s latest financial reports and current stock price. The company's current Current Ratio is 12.95. This represents a change of 26.10% compared to the average of 10.27 of the last 4 quarters.

Prescient Therapeutics Limited (PSTTF) Historical Current Ratio (quarterly & annually)

How has PSTTF Current Ratio performed in the past?

The mean historical Current Ratio of Prescient Therapeutics Limited over the last ten years is 14.87. The current 12.95 Current Ratio has changed 8.61% with respect to the historical average. Over the past ten years (40 quarters), PSTTF's Current Ratio was at its highest in in the December 2020 quarter at 80.10. The Current Ratio was at its lowest in in the December 2006 quarter at 0.

Prescient Therapeutics Limited (PSTTF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Prescient Therapeutics Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Prescient Therapeutics Limited (PSTTF) Average Current Ratio

How has PSTTF Current Ratio performed in the past?

The current Current Ratio of Prescient Therapeutics Limited (PSTTF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Prescient Therapeutics Limited (PSTTF) Current Ratio vs. Peers

How is PSTTF’s Current Ratio compared to its peers?

Prescient Therapeutics Limited’s Current Ratio is less than Eupraxia Pharmaceuticals Inc. (19.30), greater than AnGes, Inc. (1.97), greater than Adocia S.A. (1.19), greater than Ascentage Pharma Group International (1.79), greater than Mind Cure Health Inc. (4.76), greater than Anteris Technologies Ltd (0.73), greater than China Medical & HealthCare Group Limited (2.15), greater than Leafly Holdings, Inc. (0.37), greater than Japan Medical Dynamic Marketing, Inc. (3.23), greater than Cell MedX Corp. (0.03),

Build a custom stock screener for Prescient Therapeutics Limited (PSTTF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Prescient Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Prescient Therapeutics Limited (PSTTF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Prescient Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.